A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer - Concepedia

Concepedia

Publication | Closed Access

A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer

48

Citations

19

References

2021

Year

Hiroyuki Yasuda, Eiki Ichihara, Jun Sakakibara‐Konishi, Yoshitaka Zenke, Shinji Takeuchi, Masahiro Morise, Katsuyuki Hotta, Mineyoshi Sato, Shingo Matsumoto, Azusa Tanimoto,

Phase I/ii StudyMedicinePathologyBronchial NeoplasmCancer GeneticsOncologyCell BiologyLung CancerCancer ResearchCancer Growth

References

	Year	Citations

Page 1

Page 1